ESC Premium Access

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study

Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
3 presentations
0 follower

4 more presentations in this session

Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes

Speaker: Assistant Professor Y. Kim (Gwangju, KR)

Thumbnail

Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)

Speaker: Doctor M. Anjum (Baerum, NO)

Thumbnail

Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Low incidence of major complications after the first six hours post-atrial fibrillation ablation - same-day discharge safe and feasible in most patients

Speaker: Doctor A. Paul Nordin (Stockholm, SE)

Thumbnail

Access the full session

Clinical questions: management of patients with atrial fibrillation

Speakers: Doctor T. Chao, Assistant Professor Y. Kim, Doctor M. Anjum, Professor L. Fauchier, Doctor A. Paul Nordin
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Introduction.

24 October 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

This platform is supported by

logo Novo Nordisk